A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat G. StormQ. G. C. M. van HoeselF. C. Hillen Original Articles Pages: 341 - 348
Modulation of the antineoplastic efficacy of mitomycin C by dicoumarol in vivo Sara RockwellSusan R. KeyesAlan C. Sartorelli Original Articles Pages: 349 - 353
Metabolism and pharmacokinetics of p-(3,3-dimethyl-1-triazeno) benzoic acid in M5076 sarcoma-bearing mice Emilio BenfenatiPierluigi FarinaMaurizio D'Incalci Original Articles Pages: 354 - 358
Two antiemetic regimens do not impair chemical xenogenization induced in vivo by 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide Paola BalleriniAnnibale FranchiEnzo Bonmassar Original Articles Pages: 359 - 362
Factors causing dose variability in drug administration Romano DemicheliAntonio JirilloMario Balli Original Articles Pages: 363 - 366
Reversal of multidrug resistance by new dihydropyridines with lower calcium antagonistic activity Tomoko YoshinariYoshikazu IwasawaAkira Okura Original Articles Pages: 367 - 370
Clinical pharmacology of N4-palmitoyl-1-β-d-arabinofuranosylcytosine in patients with hematologic malignancies Takanori UedaToru NakamuraHaruto Uchino Original Articles Pages: 371 - 375
Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma Stefan S. BielackRudolf ErttmannCooperative Osteosarcoma Study Group COSS) Original Articles Pages: 376 - 380
Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancer F. FigoliA. VeronesiS. Monfardini Original Articles Pages: 381 - 385
Pharmacokinetics of high-dose busulfan in children G. VassalA. GouyetteJ. Lemerle Original Articles Pages: 386 - 390
Phase II clinical trial of high-dose recombinant human tumor necrosis factor H. LenkSt. TannebergerT. Shiga Short Communication Pages: 391 - 392
Intralymphatic infusion of interferon in patients with lymph nodal metastases from melanoma of the lower limbs Efisio SulisCarlo FlorisCarlo Massidda Short Communication Pages: 393 - 394
Ifosfamide cardiotoxicity in humans K. KandylisM. VassilomanolakisA. P. Efremidis Short Communication Pages: 395 - 396
Circadian pharmacokinetics of methotrexate Bridget A. RobinsonEvan J. BeggJohn R. Sharman Short Communication Pages: 397 - 399
Removal of methotrexate by hemodiafiltration N. MontagneG. MilanoM. Schneider Letter to the Editors Pages: 400 - 401